Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey.
de Azambuja, E
De Mattos-Arruda, L
MetadataShow full item record
Background:Burnout in health care professionals could have serious negative consequences on quality of patient care, professional satisfaction and personal life. Our aim was to investigate the burnout prevalence, work and lifestyle factors potentially affecting burnout amongst European oncologists ≤40 (YOs). Methods:A survey was conducted using the validated Maslach Burnout Inventory (MBI) and additional questions exploring work/lifestyle factors. Statistical analyses were carried out to identify factors associated with burnout. Results:Total of 737 surveys (all ages) were collected from 41 European countries. Countries were divided into six regions. Results from 595 (81%) YOs were included (81% medical oncologists; 52% trainees, 62% women). Seventy-one percent of YOs showed evidence of burnout (burnout subdomains: depersonalization 50%; emotional exhaustion 45; low accomplishment 35%). Twenty-two percent requested support for burnout during training and 74% reported no hospital access to support services. Burnout rates were significantly different across Europe (P < 0.0001). Burnout was highest in central European (84%) and lowest in Northern Europe (52%). Depersonalization scores were higher in men compared with women (60% versus 45% P = 0.0001) and low accomplishment was highest in the 26-30 age group (P < 0.01). In multivariable linear regression analyses, European region, work/life balance, access to support services, living alone and inadequate vacation time remained independent burnout factors (P < 0.05). Conclusions:This is the largest burnout survey in European Young Oncologists. Burnout is common amongst YOs and rates vary across Europe. Achieving a good work/life balance, access to support services and adequate vacation time may reduce burnout levels. Raising awareness, support and interventional research are needed.
Version of record
Attitude of Health Personnel
Health Knowledge, Attitudes, Practice
Quality of Life
Patient Acceptance of Health Care
License start date
Annals of oncology : official journal of the European Society for Medical Oncology, 2017, 28 (7), pp. 1590 - 1596
Showing items related by title, author, creator and subject.
Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patients. Farag, S; van Coevorden, F; Sneekes, E; Grunhagen, DJ; Reyners, AKL; Boonstra, PA; van der Graaf, WT; Gelderblom, HJ; Steeghs, N (2017-11)Although gastrointestinal stromal tumours (GIST) predominantly occur in older patients, data on treatment patterns in elderly GIST patients are scarce.Patients registered in the Dutch GIST Registry (DGR) from January 2009 ...
The Patient Deficit Model Overturned: a qualitative study of patients' perceptions of invitation to participate in a randomized controlled trial comparing selective bladder preservation against surgery in muscle invasive bladder cancer (SPARE, CRUK/07/011). Moynihan, C; Lewis, R; Hall, E; Jones, E; Birtle, A; Huddart, R; SPARE Trial Management Group (2012-11-29)Evidence suggests that poor recruitment into clinical trials rests on a patient 'deficit' model - an inability to comprehend trial processes. Poor communication has also been cited as a possible barrier to recruitment. A ...
Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective. Moreno, L; Pearson, ADJ; Paoletti, X; Jimenez, I; Geoerger, B; Kearns, PR; Zwaan, CM; Doz, F; Baruchel, A; Vormoor, J; Casanova, M; Pfister, SM; Morland, B; Vassal, G; Innovative Therapies for Children with Cancer (ITCC) Consortium (2017-08)In the past decade, the landscape of drug development in oncology has evolved dramatically; however, this paradigm shift remains to be adopted in early phase clinical trial designs for studies of molecularly targeted agents ...